Chalasani N - Search Results

1

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; NASH CRN. Sanyal AJ, et al. Among authors: chalasani n. N Engl J Med. 2010 May 6;362(18):1675-85. doi: 10.1056/NEJMoa0907929. Epub 2010 Apr 28. N Engl J Med. 2010. PMID: 20427778 Free PMC article. Clinical Trial.

2

Severe but reversible cholestatic liver injury after pioglitazone therapy.

Pinto AG, Cummings OW, Chalasani N. Pinto AG, et al. Among authors: chalasani n. Ann Intern Med. 2002 Nov 19;137(10):857. doi: 10.7326/0003-4819-137-10-200211190-00023. Ann Intern Med. 2002. PMID: 12435231 No abstract available.

3

Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?

Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV. Chalasani N, et al. Am J Gastroenterol. 2003 Dec;98(12):2771-6. doi: 10.1111/j.1572-0241.2003.08767.x. Am J Gastroenterol. 2003. PMID: 14687831

4

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

Vuppalanchi R, Teal E, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Am J Med Sci. 2005 Feb;329(2):62-5. doi: 10.1097/00000441-200502000-00002. Am J Med Sci. 2005. PMID: 15711421

5

Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.

Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. J Clin Gastroenterol. 2005 Mar;39(3):237-42. doi: 10.1097/01.mcg.0000152747.79773.2f. J Clin Gastroenterol. 2005. PMID: 15718867

6

Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.

Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA. Chalasani N, et al. J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85. doi: 10.1210/jc.2006-0075. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595594

7

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

Vuppalanchi R, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2006 Jul;4(7):838-9. doi: 10.1016/j.cgh.2006.04.020. Clin Gastroenterol Hepatol. 2006. PMID: 16829348 No abstract available.

8

Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices.

Vuppalanchi R, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Gastroenterology. 2006 Aug;131(2):674-6; discussion 676. doi: 10.1053/j.gastro.2006.01.090. Gastroenterology. 2006. PMID: 16890623 No abstract available.

9

Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.

Vuppalanchi R, Chalasani N, Saxena R. Vuppalanchi R, et al. Among authors: chalasani n. Am J Surg Pathol. 2006 Dec;30(12):1619-23. doi: 10.1097/01.pas.0000213342.78475.48. Am J Surg Pathol. 2006. PMID: 17122520

10

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Vuppalanchi R, Liangpunsakul S, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Am J Gastroenterol. 2007 Mar;102(3):558-62; quiz 693. doi: 10.1111/j.1572-0241.2006.01019.x. Am J Gastroenterol. 2007. PMID: 17156142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters